These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28406185)

  • 41. Autophagic homeostasis is required for the pluripotency of cancer stem cells.
    Sharif T; Martell E; Dai C; Kennedy BE; Murphy P; Clements DR; Kim Y; Lee PW; Gujar SA
    Autophagy; 2017 Feb; 13(2):264-284. PubMed ID: 27929731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ferritin heavy chain is a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transition.
    Lobello N; Biamonte F; Pisanu ME; Faniello MC; Jakopin Ž; Chiarella E; Giovannone ED; Mancini R; Ciliberto G; Cuda G; Costanzo F
    Oncotarget; 2016 Sep; 7(38):62019-62033. PubMed ID: 27566559
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients.
    Di J; Duiveman-de Boer T; Zusterzeel PL; Figdor CG; Massuger LF; Torensma R
    Cell Oncol (Dordr); 2013 Oct; 36(5):363-74. PubMed ID: 23928726
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Co-expressed functional module-related genes in ovarian cancer stem cells represent novel prognostic biomarkers in ovarian cancer.
    Gov E
    Syst Biol Reprod Med; 2020 Aug; 66(4):255-266. PubMed ID: 32441533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The secretome of colon cancer stem cells contains drug-metabolizing enzymes.
    Emmink BL; Verheem A; Van Houdt WJ; Steller EJ; Govaert KM; Pham TV; Piersma SR; Borel Rinkes IH; Jimenez CR; Kranenburg O
    J Proteomics; 2013 Oct; 91():84-96. PubMed ID: 23835434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
    Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
    BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 49. c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling.
    Chau WK; Ip CK; Mak AS; Lai HC; Wong AS
    Oncogene; 2013 May; 32(22):2767-81. PubMed ID: 22797058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cellular context- and protein level-dependent interaction of pluripotency factor OCT4A with multiple octamer motifs of the same target gene.
    Zhou N; Zhang XB; Chen C; Chen XY; Kang B; He JQ; Gong GZ; Wang YJ; Zhou YW
    Life Sci; 2020 May; 248():117461. PubMed ID: 32097665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs.
    Chen L; Xiao Z; Meng Y; Zhao Y; Han J; Su G; Chen B; Dai J
    Biomaterials; 2012 Feb; 33(5):1437-44. PubMed ID: 22078807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. GSKJ4, A Selective Jumonji H3K27 Demethylase Inhibitor, Effectively Targets Ovarian Cancer Stem Cells.
    Sakaki H; Okada M; Kuramoto K; Takeda H; Watarai H; Suzuki S; Seino S; Seino M; Ohta T; Nagase S; Kurachi H; Kitanaka C
    Anticancer Res; 2015 Dec; 35(12):6607-14. PubMed ID: 26637876
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oct4A is expressed by a subpopulation of prostate neuroendocrine cells.
    Sotomayor P; Godoy A; Smith GJ; Huss WJ
    Prostate; 2009 Mar; 69(4):401-10. PubMed ID: 19058139
    [TBL] [Abstract][Full Text] [Related]  

  • 54. iTRAQ-based proteomic analysis of polyploid giant cancer cells and budding progeny cells reveals several distinct pathways for ovarian cancer development.
    Zhang S; Mercado-Uribe I; Hanash S; Liu J
    PLoS One; 2013; 8(11):e80120. PubMed ID: 24348907
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proteomics Analysis of Ovarian Cancer Cell Lines and Tissues Reveals Drug Resistance-associated Proteins.
    Cruz IN; Coley HM; Kramer HB; Madhuri TK; Safuwan NA; Angelino AR; Yang M
    Cancer Genomics Proteomics; 2017 Jan; 14(1):35-51. PubMed ID: 28031236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DNA methylation of the Oct4A enhancers in embryonal carcinoma cells after etoposide treatment is associated with alternative splicing and altered pluripotency in reversibly senescent cells.
    Baryshev M; Inashkina I; Salmina K; Huna A; Jackson TR; Erenpreisa J
    Cell Cycle; 2018; 17(3):362-366. PubMed ID: 29372665
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Secretome protein signature of human pancreatic cancer stem-like cells.
    Brandi J; Dalla Pozza E; Dando I; Biondani G; Robotti E; Jenkins R; Elliott V; Park K; Marengo E; Costello E; Scarpa A; Palmieri M; Cecconi D
    J Proteomics; 2016 Mar; 136():1-12. PubMed ID: 26850699
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Understanding the Role of the Transcription Factor Sp1 in Ovarian Cancer: from Theory to Practice.
    Vellingiri B; Iyer M; Devi Subramaniam M; Jayaramayya K; Siama Z; Giridharan B; Narayanasamy A; Abdal Dayem A; Cho SG
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human mid-trimester amniotic fluid (stem) cells lack expression of the pluripotency marker OCT4A.
    Vlahova F; Hawkins KE; Ranzoni AM; Hau KL; Sagar R; De Coppi P; David AL; Adjaye J; Guillot PV
    Sci Rep; 2019 May; 9(1):8126. PubMed ID: 31148575
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Generation of Polyploid Giant Cancer Cells (PGCCs) from Hey Ovarian Cancer Cells and Analysis of Embryonic Properties.
    Niu N; Liu J
    Methods Mol Biol; 2024; 2825():281-292. PubMed ID: 38913316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.